Neil W. Peterson - 01 Aug 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
01 Aug 2022
Net transactions value
-$168,200
Form type
4
Filing time
03 Aug 2022, 20:17:02 UTC
Previous filing
29 Apr 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock Options Exercise $64,200 +4,000 $16.05* 4,000 01 Aug 2022 Direct
transaction MMSI Common Stock Sale $232,400 -4,000 -100% $58.10 0 01 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -4,000 -100% $0.000000* 0 01 Aug 2022 Common Stock 4,000 $16.05 Direct F2
holding MMSI Non-qualified stock options (right to buy) 16,000 01 Aug 2022 Common Stock 16,000 $28.20 Direct F3
holding MMSI Non-qualified stock options (right to buy) 15,000 01 Aug 2022 Common Stock 15,000 $44.80 Direct F4
holding MMSI Non-qualified stock options (right to buy) 20,000 01 Aug 2022 Common Stock 20,000 $54.40 Direct F5
holding MMSI Non-qualified stock options (right to buy) 25,000 01 Aug 2022 Common Stock 25,000 $68.33 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.64 to $60.99, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Became exercisable in equal annual installments of 20% commencing 1/28/2017.
F3 Became exercisable in equal annual installments of 20% commencing 4/14/2018.
F4 Became exercisable in equal annual installments of 20% commencing 3/2/2019.
F5 Became exercisable in equal annual installments of 20% commencing 4/25/2020.
F6 Became exercisable in equal annual installments of 25% commencing 8/19/2022.